Safety and tolerability of omalizumab in patients with chronic idiopathic/spontaneous urticaria: Results from the OPTIMA study

被引:0
|
作者
Sussman, Gordon [1 ]
Hebert, Jacques [2 ]
Gooderham, Melinda [3 ,4 ]
Gulliver, Wayne [5 ]
Lynde, Charles W. [6 ]
Papp, Kim A. [7 ]
Yang, William H. [8 ]
de Takacsy, Frederica [9 ]
Chambenoit, Olivier [9 ]
Rihakova, Lenka [9 ]
机构
[1] Univ Toronto, Dept Med, Toronto, ON, Canada
[2] CHU Laval, Dept Med, Laval, PQ, Canada
[3] SKiN Ctr Dermatol & Prob Med Res, Peterborough, ON, Canada
[4] Queens Univ, Kingston, ON, Canada
[5] Mem Univ Newfoundland, Fac Med, St John, NF, Canada
[6] Lynde Inst Dermatol & Prob Med Res, Markham, ON, Canada
[7] Ottawa Allergy Res Corp, Ottawa, ON, Canada
[8] Univ Ottawa, Med Sch, Ottawa, ON, Canada
[9] Novartis Pharmaceut Canada, Dorval, PQ, Canada
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
6221
引用
收藏
页码:AB250 / AB250
页数:1
相关论文
共 50 条
  • [1] Omalizumab retreatment of patients with chronic idiopathic urticaria / chronic spontaneous urticaria following return of symptoms: primary results of the optima study
    Sussman, G.
    Hebert, J.
    Gulliver, W.
    Lynde, C. W.
    Yang, W.
    Chambenoit, O.
    Vieria, A.
    Detakacsy, F.
    Rihakova, L.
    ALLERGY, 2017, 72 : 327 - 327
  • [2] Safety of omalizumab in patients with chronic idiopathic/spontaneous urticaria
    Maurer, M.
    Rosen, K.
    Hsieh, H.
    Blogg, M.
    Georgiou, P.
    Braeutigam, M.
    Saini, S.
    ALLERGY, 2012, 67 : 497 - 498
  • [3] Omalizumab Therapy Response with gradual Dose Increase in Patients with chronic spontaneous Urticaria: Results of the OPTIMA Study
    Gulliver, Wayne
    Sussman, Gordon
    Hebert, Jaques
    Lynde, Charles
    Papp, Kim Alexander
    Yang, William H.
    Chambenoit, Olivier
    Vieira, Antonio
    deTakacsy, Frederica
    Rihakova, Lenka
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2018, 16 : 11 - 11
  • [4] Safety of omalizumab in elderly patients with chronic spontaneous urticaria
    Narvaez Fernandez, E. J.
    Mir Ihara, P. K.
    Caballero Molina, T.
    Dominguez-Ortega, J.
    Cabanas Moreno, R.
    Entrala Bueso, A.
    ALLERGY, 2021, 76 : 234 - 234
  • [5] Efficacy and safety of omalizumab in Japanese and Korean patients with chronic spontaneous/idiopathic urticaria (CSU/CIU): Results from the phase III POLARIS study
    Hide, Michihiro
    Park, Hae-Sim
    Igarashi, Atsuyuki
    Ye, Young Min
    Kim, Tae-Bum
    Yagami, Akiko
    Lee, Jae-Hyun
    Fukunaga, Atsushi
    Khalil, Sam
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB112 - AB112
  • [6] Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria
    Maurer, Marcus
    Rosen, Karin
    Hsieh, Hsin-Ju
    Saini, Sarbjit
    Grattan, Clive
    Gimenez-Arnau, Ana
    Agarwal, Sunil
    Doyle, Ramona
    Canvin, Janice
    Kaplan, Allen
    Casale, Thomas
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (10): : 924 - 935
  • [7] Design and rationale of the optima study: retreatment or step-up therapy with omalizumab in patients with chronic idiopathic/spontaneous urticaria (CIU/CSU)
    Sussman, G.
    Hebert, J.
    Gulliver, W.
    Lynde, C. W.
    Yang, W. H.
    Deutsch, G.
    Chambenoit, O.
    Detakascy, F.
    Rihakova, L.
    ALLERGY, 2017, 72 : 713 - 713
  • [8] Timing and duration of omalizumab response in patients with chronic idiopathic/spontaneous urticaria
    Kaplan, Allen
    Ferrer, Marta
    Bernstein, Jonathan A.
    Antonova, Evgeniya
    Trzaskoma, Benjamin
    Raimundo, Karina
    Rosen, Karin
    Omachi, Theodore A.
    Khalil, Sam
    Zazzali, James L.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : 474 - 481
  • [9] Omalizumab for the treatment of chronic idiopathic/spontaneous urticaria in children
    Licari, A.
    Castagnoli, R.
    De Filippo, M.
    Mascolo, A.
    Ruffinazzi, G.
    Marseglia, A.
    Leone, M.
    Marseglia, G.
    ALLERGY, 2017, 72 : 322 - 323
  • [10] Commentary: Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria
    Sabroe, R. A.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 (01) : 13 - 15